MDCO - The Medicines Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.72B
Enterprise Value 33.12B
Trailing P/E N/A
Forward P/E 1-9.86
PEG Ratio (5 yr expected) 1-0.27
Price/Sales (ttm)-824.76
Price/Book (mrq)71.16
Enterprise Value/Revenue 3-945.64
Enterprise Value/EBITDA 6-19.59

Trading Information

Stock Price History

Beta (3Y Monthly) 1.80
52-Week Change 3-15.80%
S&P500 52-Week Change 31.52%
52 Week High 341.33
52 Week Low 316.69
50-Day Moving Average 335.43
200-Day Moving Average 331.36

Share Statistics

Avg Vol (3 month) 31.5M
Avg Vol (10 day) 31.06M
Shares Outstanding 573.61M
Float 74.02M
% Held by Insiders 14.86%
% Held by Institutions 1132.60%
Shares Short (Jul 31, 2019) 421M
Short Ratio (Jul 31, 2019) 415.65
Short % of Float (Jul 31, 2019) 487.07%
Short % of Shares Outstanding (Jul 31, 2019) 426.47%
Shares Short (prior month Jun 28, 2019) 423.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)4,911.52%

Management Effectiveness

Return on Assets (ttm)-11.56%
Return on Equity (ttm)-727.27%

Income Statement

Revenue (ttm)-3.3M
Revenue Per Share (ttm)-0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-517k
EBITDA -159.33M
Net Income Avi to Common (ttm)-215.85M
Diluted EPS (ttm)-2.96
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)323.68M
Total Cash Per Share (mrq)4.09
Total Debt (mrq)856.66M
Total Debt/Equity (mrq)2,246.74
Current Ratio (mrq)5.97
Book Value Per Share (mrq)0.48

Cash Flow Statement

Operating Cash Flow (ttm)-195.05M
Levered Free Cash Flow (ttm)-132.88M